Willkommen in unserem Pressezentrum! Hier werfen wir einen genaueren Blick auf Forschungs- und Entwicklungsgeschichten, Trends und Entwicklungen, die die verschiedenen Bereiche, in denen unsere Kunden und Partner arbeiten, beeinflussen.
10 May 2022We are happy to announce that Micronbrane Medical was selected by SOSA for IP2 Scaleout Program in USA. IP2 Scaleout Program is 14 months intensive accelerator program for CEO & founders that are eager to launch, grow and scale their businesses of innovative products and technologies on the global markets. Micronbrane Medical thanks SOSA and i2i for support and trust.
4 May 2022Access poster and online video presentation of Micronbrane Medical and materials of other participants of ECCMID 2022 in the Online Library of ESCMID!
4 May 2022We are happy to announce that Micronbrane Medical was chosen to join and present Taiwan at SelectUSA 2022 Event!
25 April 2022We are happy to announce that Micronbrane Medical was chosen to present poster in Poster Session at EECMID 2022 in Lisbon Portugal in the section "Microbiome studies, clinical and diagnostic studies and One Health aspects"
29 March 2022Current diagnosis and research protocols use lysis depletion to avoid host DNA interference and further detect the pathogen involved in infectious diseases. But are all lysis depletion methods just as efficient in reducing host DNA and preserving the microbial community intact? Let's find out how most host DNA depletion methods work compared to the newly developed ones.
22 March 2022Biofouling resistance of PP membranes is significantly improved with surface zwitterionization for leukocyte reduction filters. Micronbrane enhanced this technique and developed zwitterionic interface ultra-self-assemble coating technology (global patent) used in Devin filter. The developed membrane can remove more than 95% of nucleated cells from whole blood samples within just 5 minutes. Let's see how it works.
14 March 2022Many threatening pathogens are now resistant to multiple classes of antimicrobial agents. A study tested 500 Streptomyces strains isolated from soil against 21 antibiotics of different class found that all the strains were multidrug resistant to at least 7 of the tested antibiotics (D’Costa et al., 2006). These multidrug-resistant (MDR) organisms cause infections that may compromise effective therapy and limit treatment options.
7 March 2022Infective endocarditis is inflammation of endocardium that usually affects heart valves. Mortality rate of the disease is up to 30% in 1st year for many malignant cancers. The most common risk factors for infective endocarditis include previous heart damage, recent heart surgery or poor dental hygiene. According to report of National Organization for Rare Diseases, people over the age of 50 with prosthetic heart valves or cardiac pacemakers are more prone to develop endocarditis.
1 March 2022Many DNA sequences, including cfDNA fragments, are species-specific and with the development of next-generation sequencing (NGS) technology, these molecules have been described as a promising, non-invasive tool for the early detection of several human diseases, including sepsis for which the latest research have reported significantly elevated fractions of cfDNA from retrotransposable elements in blood.
17 February 2022It has been nearly two years since the global healthcare resources have been diverted into the prolonged fight against the SARS-CoV2 pandemic, often being forced to put other medical issues and emergencies on hold. Aside from the undeniable threat of the COVID-19 crisis, there are other urgent challenges to the health of the general population, such as the accelerating development of resistance to antimicrobials, seen among many harmful pathogens.